Assessing venous congestion in ICU patients on mechanical ventilation
Hepatic Doppler to Assess Venous Congestion During Invasive Mechanical Ventilation
This study is testing how well a special ultrasound can help doctors understand and manage blood flow issues in ICU patients on breathing machines.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 1 site (Brest) |
| Trial ID | NCT06914336 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate venous congestion in ICU patients who are undergoing invasive mechanical ventilation by using hepatic vein Doppler ultrasound. The primary focus is to measure the systolic to diastolic hepatic vein velocity ratio (S/D) and to explore its correlation with various indicators of congestion. By analyzing these relationships, the study seeks to enhance understanding of venous congestion in critically ill patients and improve management strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are ICU patients who have been intubated for more than 24 hours.
Not a fit: Patients with chronic end-stage renal disease, atrial fibrillation, cirrhosis, portal thrombosis, or those who refuse to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better monitoring and management of venous congestion in ICU patients, potentially improving patient outcomes.
How similar studies have performed: While this approach is novel in its specific application, similar studies using Doppler ultrasound for assessing venous congestion have shown promise in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * intubated for more than 24 hours Exclusion Criteria: * Chronic end-stage renal disease on admission * Atrial Fibrillation * Cirrhosis * Portal thrombosis * Refusal to participate * non-opposition could not be obtained from themselves or their trusted support person in the event of incapacity * Under legal protection.
Where this trial is running
Brest
- Chu Brest — Brest, France (Recruiting)
Study contacts
- Study coordinator: Gwenael PRAT, phD
- Email: gwenael.prat@chu-brest.fr
- Phone: 0298347181
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.